Form 4: NEOGEN CLO's RSU Vesting & Share Transactions

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of 9,036 Restricted Stock Units and a subsequent sale of 3,534 shares for tax purposes on October 7, 2025.

Summary

• Amy M. Rocklin, Chief Legal Officer of NEOGEN CORP, reported transactions that occurred on October 7, 2025.
• Acquired 9,036 shares of NEOGEN common stock through the vesting of Restricted Stock Units (RSUs) at an exercise price of $5.36 per share.
• Disposed of 3,534 shares of common stock at a price of $5.63 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, her direct beneficial ownership of NEOGEN common stock is 49,672 shares.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The vesting of RSUs is a positive sign of executive compensation and retention, while the sale for tax purposes is a routine event. No significant positive or negative operational news is conveyed.

Positives

• The vesting of Restricted Stock Units indicates continued long-term incentive alignment for a key executive.
• The executive's beneficial ownership remains substantial at 49,672 shares, demonstrating an ongoing stake in the company's performance.

Negatives

• A portion of the vested shares (3,534 shares) was sold to cover tax liabilities, which is a common practice but reduces the executive's direct holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports a routine insider transaction related to executive compensation, which is a standard practice across various industries. It does not provide information directly related to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Provides transparency on executive equity holdings and compensation, which is a standard disclosure for corporate governance.
• Employees: Reflects standard equity compensation practices for executives, which can influence broader compensation strategies.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations. Such transactions are common for executives receiving equity compensation and do not typically signal a change in the company's fundamental outlook or the executive's confidence. There is no new information in this filing that would warrant a change in investment recommendation based solely on these transactions.

Keywords

NEOGEN CORP, NEOG, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Amy M. Rocklin, Chief Legal Officer, Equity Compensation